Joshua McClure
Joshua has co-invented and secured over a dozen patents in the areas of multi-tissue regeneration and gene expression modulation in collaboration with co-inventors at his company, Stanford University, and the University of California Berkeley. McClure leads a team of some of the world's top scientists and clinicians in the field of tissue regeneration, using computational systems medicine to personalize therapies to fight chronic disease and optimize human performance.
A graduate of the USAF Academy, McClure has been a leader of tech companies for over 15 years and comes to industry with a background in top-secret USAF projects. He has invented multiple category-first companies, revolutionary new technologies and now devotes his time to biotechnologies with the capacity to reverse age-related degeneration and optimize human longevity. MaxWell is working with Mayo Clinic, The American Red Cross and other large companies to bring these technologies to humans.
A graduate of the USAF Academy, McClure has been a leader of tech companies for over 15 years and comes to industry with a background in top-secret USAF projects. He has invented multiple category-first companies, revolutionary new technologies and now devotes his time to biotechnologies with the capacity to reverse age-related degeneration and optimize human longevity. MaxWell is working with Mayo Clinic, The American Red Cross and other large companies to bring these technologies to humans.